Services

41. EDC 6/23/2011

    SGS works closely with several EDC companies, supporting web-based applications. Most recently, SGS has formalized a strategic partnership with Phase Forward for use of their InForm™ EDC solution.

42. Late Phase Pharmacovigilance 6/23/2011

    SGS Medical Affairs provides comprehensive and flexible solutions for the active management of drug safety and risk management during the complete life cycle of a medicinal product.

43. Late Phase Clinical Trial Management 6/23/2011
    SGS delivers tailor-made solutions for its clients moving forward into Late Phase clinical trials. With a highly experienced team of Project Managers and CRA’s, SGS provides clients with confidence that their project will be successfully completed on time, on budget and exceeding quality standards.
44. Biologics: From Molecule To Market 6/23/2011
    Developing a biologic therapy for market takes a special kind of expertise. SGS Life Science Services works with its clients to meet their specific needs in this complex field.
45. Pharmacovigilance 6/23/2011

    SGS Medical Affairs provides comprehensive and flexible solutions for the active management of drug safety and risk management during the complete life cycle of a medicinal product.

46. Data Management Services 6/22/2011
    SGS’s Data Management team has over 15 years of experience providing unparalleled service with an understanding for individual clients’ needs.
47. Biometrics 6/21/2011
    SGS’s Data Management team has over 15 years of experience providing unparalleled service with an understanding for individual clients’ needs.
48. InVitro Assays 6/21/2011
    SGS provides several in vitro assays to support drug development and testing.
49. ADME 6/21/2011
    SGS’ Life Science Services provides an extensive pharmacokinetic (PK) and pharmacodynamic (PD) support in pre-clinical and Phase I-III clinical studies in accordance with international regulatory standards (FDA, EMEA, ICH).
50. Public Health And Government Services 5/20/2011
    Navigating the complexities of clinical development for government and other subsidized programs requires a partner who has a combination of therapeutic expertise and experience in the public health sector.